Kezar Life Sciences Inc. (KZR) NASDAQ

$0.90 - (-)

Market Cap: $65.74M

As of 03/28/24 03:59 PM EDT. Market closed.

(KZR)

Kezar Life Sciences Inc. (KZR)
NASDAQ

$0.90
- (-)

Market Cap: $65.74M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus ... read more

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
John Fowler
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.80M
URL
Address
4000 Shoreline Ct Ste 300, California, South San Francisco, 94080-2005.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
John Fowler
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.80M
Address
4000 Shoreline Ct Ste 300, California, South San Francisco, 94080-2005.
PRICE CHART FOR KEZAR LIFE SCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.94
Previous Close
$0.90
Days Range
$0.85 - $0.91
52 week range
$0.67 - $3.37
Volume
1,156,913
Avg. Volume (30 days)
877,933
Market Cap
$65.74M
Dividend Yield
-
P/E
-
Shares Outstanding
72,801,359
Open
$0.94
Previous Close
$0.90
Days Range
$0.85 - $0.91
52 week range
$0.67 - $3.37
Volume
1,156,913
Avg. Volume (30 days)
877,933
Market Cap
$65.74M
Dividend Yield
-
P/E
-
Shares Outstanding
72,801,359
FINANCIAL STATEMENTS FOR KEZAR LIFE SCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KEZAR LIFE SCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kirk Christopher J.DirectorJul 20, 2023 Option Exercise$0.9048,95044,055431,348Jul 24, 2023, 04:20 PM
Morningside Venture Investments Ltd10% OwnerFeb 06, 2023 Sale$6.8840,000275,3205,447,993Feb 07, 2023, 04:11 PM
Morningside Venture Investments Ltd10% OwnerFeb 03, 2023 Sale$7.1525,000178,6505,487,993Feb 07, 2023, 04:11 PM
Morningside Venture Investments Ltd10% OwnerFeb 02, 2023 Sale$7.1950,000359,5005,512,993Feb 03, 2023, 04:32 PM
Morningside Venture Investments Ltd10% OwnerFeb 01, 2023 Sale$6.9540,000278,0005,562,993Feb 03, 2023, 04:32 PM
Morningside Venture Investments Ltd10% OwnerJan 31, 2023 Sale$7.0830,000212,4005,602,993Feb 01, 2023, 04:07 PM
Morningside Venture Investments Ltd10% OwnerJan 30, 2023 Sale$6.9130,000207,3005,632,993Feb 01, 2023, 04:07 PM
Morningside Venture Investments Ltd10% OwnerJan 25, 2023 Sale$6.8550,000342,5005,662,993Jan 27, 2023, 04:17 PM
Morningside Venture Investments Ltd10% OwnerJan 24, 2023 Sale$6.9880,000558,4005,712,993Jan 25, 2023, 06:17 PM
Morningside Venture Investments Ltd10% OwnerJan 23, 2023 Sale$6.8180,000544,8005,792,993Jan 25, 2023, 06:17 PM
Morningside Venture Investments Ltd10% OwnerJan 17, 2023 Sale$6.796,11441,5145,872,993Jan 19, 2023, 04:12 PM
Morningside Venture Investments Ltd10% OwnerJan 13, 2023 Sale$7.151,97114,0935,879,107Jan 17, 2023, 04:28 PM
Morningside Venture Investments Ltd10% OwnerJan 12, 2023 Sale$6.775,00033,8505,881,078Jan 17, 2023, 04:28 PM
Morningside Venture Investments Ltd10% OwnerJan 06, 2023 Sale$6.893,00020,6705,886,078Jan 09, 2023, 04:08 PM
Morningside Venture Investments Ltd10% OwnerJan 05, 2023 Sale$6.9712,16284,7695,889,078Jan 09, 2023, 04:08 PM
Morningside Venture Investments Ltd10% OwnerJan 04, 2023 Sale$7.1730,000215,1005,901,240Jan 05, 2023, 04:10 PM
Morningside Venture Investments Ltd10% OwnerJan 03, 2023 Sale$7.105003,5505,931,240Jan 05, 2023, 04:10 PM
Morningside Venture Investments Ltd10% OwnerDec 29, 2022 Sale$7.1025,000177,5005,931,740Jan 05, 2023, 04:10 PM
Fowler John FranklinCEONov 10, 2022 Option Exercise$0.9027,00024,300393,904Nov 14, 2022, 08:13 AM
Morningside Venture Investments Ltd10% OwnerOct 03, 2022 Sale$8.7828,700251,9576,080,352Oct 05, 2022, 04:05 PM
Morningside Venture Investments Ltd10% OwnerOct 04, 2022 Sale$8.823,61231,8576,076,740Oct 05, 2022, 04:05 PM
Kirk Christopher J.President and CSOJun 23, 2022 Option Exercise$0.9033,06029,754381,484Jun 27, 2022, 06:30 PM
BERGER FRANKLIN MDirectorMar 21, 2022 Buy$14.7720,000295,400890,691Mar 22, 2022, 05:45 PM
BERGER FRANKLIN MDirectorMar 18, 2022 Buy$16.7460,0001,004,400870,691Mar 22, 2022, 05:45 PM
Kauffman MichaelDirectorJan 03, 2022 Option Exercise$5.915,00029,55068,690Jan 05, 2022, 06:51 PM
Kauffman MichaelDirectorJan 03, 2022 Sale$16.455,00082,25063,690Jan 05, 2022, 06:51 PM
Fowler John FranklinCEODec 14, 2021 Option Exercise$0.907,7006,930366,904Dec 15, 2021, 06:05 PM
BERGER FRANKLIN MDirectorSep 22, 2021 Option Exercise$5.608,89649,818810,691Sep 23, 2021, 04:26 PM
BERGER FRANKLIN MDirectorSep 21, 2021 Option Exercise$6.7717,792120,452801,795Sep 23, 2021, 04:26 PM
Economides VassilikiSVP, Strategy & External Aff.May 30, 2019 Buy$10.197507,64211,320Mar 29, 2021, 05:55 PM
Fowler John FranklinCEODec 31, 2020 Option Exercise$0.9016,00014,400359,204Jan 04, 2021, 08:45 PM
Equal Talent Investments Ltd10% OwnerJun 11, 2020 Buy$5.501,454,5457,999,9986,254,545Jun 15, 2020, 04:10 PM
BERGER FRANKLIN MDirectorJun 11, 2020 Buy$5.50100,000550,000784,003Jun 11, 2020, 06:29 PM
Morningside Venture Investments Ltd10% OwnerFeb 04, 2020 Buy$2.603,800,0009,880,0006,109,052Feb 06, 2020, 04:11 PM
Fowler John FranklinCEOFeb 04, 2020 Buy$2.6038,46199,99938,461Feb 05, 2020, 08:21 PM
Belsky MarcCFOFeb 04, 2020 Buy$2.6015,38439,99815,384Feb 05, 2020, 08:19 PM
Economides VassilikiSVP, Strategy & External Aff.Feb 04, 2020 Buy$2.605,76914,9997,570Feb 05, 2020, 08:17 PM
BERGER FRANKLIN MDirectorFeb 04, 2020 Buy$2.60120,846314,200684,003Feb 05, 2020, 08:15 PM
Kirk Christopher J.President and CSOFeb 04, 2020 Buy$2.6038,46199,999342,609Feb 05, 2020, 08:13 PM
Fowler John FranklinCEODec 19, 2019 Option Exercise$0.9050,00045,000346,954Dec 20, 2019, 04:29 PM
Belsky MarcCFONov 13, 2019 Buy$2.768002,2072,000Nov 13, 2019, 07:07 PM
Fowler John FranklinCEOOct 10, 2019 Buy$3.241,0003,235296,954Oct 11, 2019, 04:24 PM
Belsky MarcCFOAug 20, 2019 Buy$4.422008841,200Aug 21, 2019, 07:38 PM
Economides VassilikiSVP, Strategy & External Aff.Aug 20, 2019 Buy$4.413501,5441,801Aug 21, 2019, 07:29 PM
Kirk Christopher J.President and CSOAug 13, 2019 Buy$4.615,00023,040302,934Aug 15, 2019, 07:25 PM
Fowler John FranklinCEOAug 13, 2019 Buy$4.662,0009,310295,954Aug 14, 2019, 08:04 PM
Kirk Christopher J.President and CSOAug 09, 2019 Buy$4.975,00024,830297,934Aug 12, 2019, 07:51 PM
Fowler John FranklinCEOAug 09, 2019 Buy$5.017503,761293,954Aug 12, 2019, 07:47 PM
Fowler John FranklinCEOAug 09, 2019 Buy$5.265002,628293,204Aug 12, 2019, 07:47 PM
Economides VassilikiSVP, Strategy & External Aff.Aug 09, 2019 Buy$4.961,0205,0571,451Aug 12, 2019, 07:43 PM
Belsky MarcCFOAug 09, 2019 Buy$4.825002,4101,000Aug 12, 2019, 07:41 PM
Belsky MarcCFOJul 25, 2019 Buy$5.654442,510444Jul 26, 2019, 05:14 PM
Belsky MarcCFOJul 26, 2019 Buy$5.8056325500Jul 26, 2019, 05:14 PM
Economides VassilikiSVP, Strategy & External Aff.Jul 22, 2019 Buy$5.824312,509431Jul 23, 2019, 04:59 PM
BAY CITY CAPITAL LLC10% OwnerJun 25, 2018 Buy$15.00150,0002,250,000622,229Jun 28, 2018, 06:22 PM
Cormorant Asset Management, LP10% OwnerJun 25, 2018 Buy$15.00250,0003,750,0001,572,909Jun 27, 2018, 06:20 PM
Morningside Venture Investments Ltd10% OwnerJun 25, 2018 Buy$15.00250,0003,750,0002,309,052Jun 27, 2018, 04:53 PM
BERGER FRANKLIN MDirectorJun 25, 2018 Buy$15.0050,000750,000563,157Jun 27, 2018, 04:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kirk Christopher J.Director07/20/202344,055
Morningside Venture Investments Ltd10% Owner02/06/2023275,320
Morningside Venture Investments Ltd10% Owner02/03/2023178,650
Morningside Venture Investments Ltd10% Owner02/02/2023359,500
Morningside Venture Investments Ltd10% Owner02/01/2023278,000
Morningside Venture Investments Ltd10% Owner01/31/2023212,400
Morningside Venture Investments Ltd10% Owner01/30/2023207,300
Morningside Venture Investments Ltd10% Owner01/25/2023342,500
Morningside Venture Investments Ltd10% Owner01/24/2023558,400
Morningside Venture Investments Ltd10% Owner01/23/2023544,800
Morningside Venture Investments Ltd10% Owner01/17/202341,514
Morningside Venture Investments Ltd10% Owner01/13/202314,093
Morningside Venture Investments Ltd10% Owner01/12/202333,850
Morningside Venture Investments Ltd10% Owner01/06/202320,670
Morningside Venture Investments Ltd10% Owner01/05/202384,769
Morningside Venture Investments Ltd10% Owner01/04/2023215,100
Morningside Venture Investments Ltd10% Owner01/03/20233,550
Morningside Venture Investments Ltd10% Owner12/29/2022177,500
Fowler John FranklinCEO11/10/202224,300
Morningside Venture Investments Ltd10% Owner10/03/2022251,957
Morningside Venture Investments Ltd10% Owner10/04/202231,857
Kirk Christopher J.President and CSO06/23/202229,754
BERGER FRANKLIN MDirector03/21/2022295,400
BERGER FRANKLIN MDirector03/18/20221,004,400
Kauffman MichaelDirector01/03/202229,550
Kauffman MichaelDirector01/03/202282,250
Fowler John FranklinCEO12/14/20216,930
BERGER FRANKLIN MDirector09/22/202149,818
BERGER FRANKLIN MDirector09/21/2021120,452
Economides VassilikiSVP, Strategy & External Aff.05/30/20197,642
Fowler John FranklinCEO12/31/202014,400
Equal Talent Investments Ltd10% Owner06/11/20207,999,998
BERGER FRANKLIN MDirector06/11/2020550,000
Morningside Venture Investments Ltd10% Owner02/04/20209,880,000
Fowler John FranklinCEO02/04/202099,999
Belsky MarcCFO02/04/202039,998
Economides VassilikiSVP, Strategy & External Aff.02/04/202014,999
BERGER FRANKLIN MDirector02/04/2020314,200
Kirk Christopher J.President and CSO02/04/202099,999
Fowler John FranklinCEO12/19/201945,000
Belsky MarcCFO11/13/20192,207
Fowler John FranklinCEO10/10/20193,235
Belsky MarcCFO08/20/2019884
Economides VassilikiSVP, Strategy & External Aff.08/20/20191,544
Kirk Christopher J.President and CSO08/13/201923,040
Fowler John FranklinCEO08/13/20199,310
Kirk Christopher J.President and CSO08/09/201924,830
Fowler John FranklinCEO08/09/20193,761
Fowler John FranklinCEO08/09/20192,628
Economides VassilikiSVP, Strategy & External Aff.08/09/20195,057
Belsky MarcCFO08/09/20192,410
Belsky MarcCFO07/25/20192,510
Belsky MarcCFO07/26/2019325
Economides VassilikiSVP, Strategy & External Aff.07/22/20192,509
BAY CITY CAPITAL LLC10% Owner06/25/20182,250,000
Cormorant Asset Management, LP10% Owner06/25/20183,750,000
Morningside Venture Investments Ltd10% Owner06/25/20183,750,000
BERGER FRANKLIN MDirector06/25/2018750,000
Load More Insider Transactions
FUNDS WITH A POSITION IN KEZAR LIFE SCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
SUVRETTA CAPITAL MANAGEMENT, LLC7,167,5910.31%No changeGrowth At A Reasonable Price
ORBIMED ADVISORS LLC1,927,0000.04%-64.73%Other
BLACKROCK INC.4,817,2660.00012%-2.73%Other
GEODE CAPITAL MANAGEMENT, LLC1,354,6480.00013%4.8%Other
RENAISSANCE TECHNOLOGIES LLC1,291,9190.00189%112.24%Other
PALO ALTO INVESTORS LP656,2000.07%ExitedOther
D. E. SHAW & CO., INC.376,9760.00031%763.14%Other
ALPS ADVISORS INC53,6250.00053%ExitedOther
ALPINE GLOBAL MANAGEMENT, LLC11,4100.01%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR KEZAR LIFE SCIENCES INC
STOCK BUYBACKS FOR KEZAR LIFE SCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.08%
1Q
12/31/2023
06/30/2023
0.38%
2Q
12/31/2023
03/31/2023
0.57%
3Q
12/31/2023
12/31/2022
0.63%
4Q
12/31/2023
09/30/2022
0.81%
5Q
12/31/2023
06/30/2022
13.16%
6Q
12/31/2023
03/31/2022
19.97%
7Q
12/31/2023
12/31/2021
29.86%
8Q
12/31/2023
09/30/2021
39.75%
9Q
12/31/2023
06/30/2021
40.14%
10Q
12/31/2023
03/31/2021
42.46%
11Q
12/31/2023
12/31/2020
45.12%
12Q
12/31/2023
09/30/2020
45.48%
13Q
12/31/2023
06/30/2020
69.41%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.08%
1Q
06/30/2023
0.38%
2Q
03/31/2023
0.57%
3Q
12/31/2022
0.63%
4Q
09/30/2022
0.81%
5Q
06/30/2022
13.16%
6Q
03/31/2022
19.97%
7Q
12/31/2021
29.86%
8Q
09/30/2021
39.75%
9Q
06/30/2021
40.14%
10Q
03/31/2021
42.46%
11Q
12/31/2020
45.12%
12Q
09/30/2020
45.48%
13Q
06/30/2020
69.41%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KEZAR LIFE SCIENCES INC
LOADING...